Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2025-10-28 00:00:00 ET · period of report 2025-10-24 · accession 0001213900-25-103147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-28 | 2025-10-24+ | CVKD | Szot Matthew K | CFO | S - Sale | $13.99 | -3,600 | 11.7K | -23% | -$50.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | S | D | 1,800 | $13.99 | 9,933 | D | — | — | (F1) Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025. |
| 2 | Common | Common Stock | 2025-10-24 | S | D | 1,800 | $13.99 | 11,733 | D | — | — | (F1) Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025. |